Finance

Lists
Why is ICLR down ၂.၆၂%?
Dive Deeper
ICLR:NASDAQ
ICON PLC
၁၈၅.၃၇ US$
-၂.၆၂%
(-၄.၉၉) 1D
နို ၂၀, GMT-၅ ၁၀:၅၁:၄၇  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ICLR...
Open
၁၉၀.၀၄ US$
High
၁၉၀.၉၇ US$
Low
၁၈၃.၉၃ US$
Mkt. cap
ဋေ ၁.၃၉ ထ
Avg. vol.
၁.၀၉ သန်း
Volume
၁.၁၈ သိန်း
P/E ratio
၇၅.၇၅
52-wk high
၂၁၉.၀၄ US$
52-wk low
၆၆.၅၇ US$
EPS
၂.၄၅ US$
Beta
၁.၁၉
Shares outstanding
၇.၄၉ ကုဋေ
No. of employees
၄ သောင်း
Open
၁၉၀.၀၄ US$
High
၁၉၀.၉၇ US$
Low
၁၈၃.၉၃ US$
Mkt. cap
ဋေ ၁.၃၉ ထ
Avg. vol.
၁.၀၉ သန်း
Volume
၁.၁၈ သိန်း
P/E ratio
၇၅.၇၅
52-wk high
၂၁၉.၀၄ US$
52-wk low
၆၆.၅၇ US$
EPS
၂.၄၅ US$
Beta
၁.၁၉
Shares outstanding
၇.၄၉ ကုဋေ
No. of employees
၄ သောင်း
News stories
From web sources and news partners
Yahoo Finance
Yahoo Finance
·
ပြီးခဲ့သည့် ၃ ရက်
ICON plc (ICLR) Stock Forecasts
Profile
Icon plc is an Irish-headquartered multinational clinical research organisation. Icon conducts clinical trials on behalf of pharmaceutical and biotechnology companies and provides services related to drug development and guiding clinical trial progress. As of December 2025 Icon had approximately 40,100 employees in 55 countries. Wikipedia
About ICON PLC
CEOBarry Balfe
Employees၄.၀၂ သောင်း
Founded၁၉၉၀
Headquarters-
SectorHealth Care
Industry-
Analyst ratings
Based on 14 analysts giving stock ratings to ICLR in the past 3 months
Buy
Buy
8
Hold
6
Sell
0
12-month forecast
Based on 14 Wall Street analysts offering 12 month price targets for ICLR in the last 3 months.
Highest
Current ၁၈၅.၃၇ US$
၂၆၈.၀၀ US$ (+၄၄.၅၈%)
Average
၂၃၀.၀၈ US$ (+၂၄.၁၂%)
Lowest
၁၈၀.၀၀ US$ (-၂.၉၀%)
Analyst
Recommendation
Action
Price target
Projected
Date
Ann Hynes
Mizuho Securities
Buy
Maintained
၂၂၈.၀၀ US$
+၂၃%
11/02/2026
Casey Woodring
J.P. Morgan
Hold
Maintained
၂၀၀.၀၀ US$
+၇.၉%
10/29/2026
Jailendra Singh
Truist Financial
Buy
Maintained
၂၆၈.၀၀ US$
+၄၄.၆%
10/29/2026
Justin Bowers
Deutsche Bank
Buy
Maintained
၂၅၀.၀၀ US$
+၃၄.၉%
10/29/2026
Charles Rhyee
TD Cowen
Buy
Maintained
၂၅၄.၀၀ US$
+၃၇%
10/29/2026
Kevin Caliendo
UBS
Hold
Reiterated
၂၃၆.၀၀ US$
+၂၇.၃%
10/29/2026
Michael Cherny
Leerink Partners
Hold
Reiterated
၂၂၀.၀၀ US$
+၁၈.၇%
10/29/2026
Sean Dodge
BMO Capital
Buy
Reiterated
၂၃၅.၀၀ US$
+၂၆.၈%
10/28/2026
Patrick B Donnelly
Citi
Hold
Maintained
၂၁၅.၀၀ US$
+၁၆%
10/29/2026
Albert Hu
Citi
Hold
Maintained
၂၁၅.၀၀ US$
+၁၆%
10/29/2026
Albert Hu
Citi
Hold
Maintained
၂၁၅.၀၀ US$
+၁၆%
10/29/2026
Eric Coldwell
Robert W. Baird
Buy
Maintained
၂၄၉.၀၀ US$
+၃၄.၃%
10/29/2026
Ryan Halsted
RBC Capital
Buy
Reiterated
၂၂၆.၀၀ US$
+၂၁.၉%
10/28/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
၁၈၀.၀၀ US$
-၂.၉%
10/28/2026
Luke Sergott
Barclays
Hold
Maintained
၂၃၀.၀၀ US$
+၂၄.၁%
10/28/2026
Lu Li
Bank of America Securities
Hold
Upgraded
-
-
10/09/2026
Michael Ryskin
Bank of America Securities
Hold
Upgraded
-
-
10/09/2026
‏Brendan Digan‏
Citi
Hold
Maintained
၁၈၀.၀၀ US$
-၂.၉%
07/31/2026
Jared Haase
William Blair
Buy
Reiterated
-
-
07/29/2026
David Windley
Jefferies
Buy
Reiterated
၁၉၃.၀၀ US$
+၄.၁%
06/25/2026
Max Smock
William Blair
Buy
Reiterated
-
-
06/02/2026
Jamie Clark
Rothschild & Co Redburn
Hold
Downgraded
၁၀၀.၀၀ US$
-၄၆.၁%
02/17/2026
Last report
၂၀၂၆ အောက် ၂၈
Fiscal period
Q3 2026
၂.၆၆ US$ / ၂.၆၃ US$
+၁.၂၅%beat
Revenue / Est. (USD)
၂၀၂.၄၈ ဋေ / ၂၀၁.၂၅ ဋေ
+၀.၆၁%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
၂၀၂၆ ဇွန်
၂၀၂၆ စက်
Revenue
၂၁၈.၉၈ ဋေ
၂၀၃.၄၀ ဋေ
၂၀၆.၃၅ ဋေ
၂၀၂.၄၈ ဋေ
Cost of goods sold
၁၆၉.၄၁ ဋေ
၁၅၅.၄၄ ဋေ
၁၅၈.၂၆ ဋေ
၁၅၃.၀၆ ဋေ
Cost of revenue
၁၆၉.၄၁ ဋေ
၁၅၅.၄၄ ဋေ
၁၅၈.၂၆ ဋေ
၁၅၃.၀၆ ဋေ
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
-၆၀.၅၀ ကုဋေ
၂၀.၂၃ ကုဋေ
၁၉.၅၉ ကုဋေ
၁၉.၀၀ ကုဋေ
Operating expense
၈၅.၀၈ ကုဋေ
၂၉.၂၆ ကုဋေ
၂၈.၆၇ ကုဋေ
၂၇.၇၀ ကုဋေ
Total operating expenses
၂၅၄.၄၉ ဋေ
၁၈၄.၇၀ ဋေ
၁၈၆.၉၃ ဋေ
၁၈၀.၇၆ ဋေ
Operating income
-၃၅.၅၀ ကုဋေ
၁၈.၇၀ ကုဋေ
၁၉.၄၂ ကုဋေ
၂၁.၇၂ ကုဋေ
Other non operating income
-၉.၃၈ သန်း
-
-
-
EBT including unusual items
-၁၄.၂၅ ကုဋေ
၁၂.၇၆ ကုဋေ
၉.၂၂ ကုဋေ
၁၅.၄၆ ကုဋေ
EBT excluding unusual items
-၄၀.၉၂ ကုဋေ
၁၄.၀၈ ကုဋေ
၁၄.၈၆ ကုဋေ
၁၇.၂၉ ကုဋေ
Income tax expense
-၁.၇၀ ကုဋေ
၂.၂၈ ကုဋေ
၁.၉၆ ကုဋေ
၃.၂၄ ကုဋေ
Effective tax rate
၁၁.၉၄%
၁၇.၈၈%
၂၁.၂၇%
၂၀.၉၉%
Other operating expenses
၁၆၉.၅၃ ဋေ
-
-
-
Net income
-၁၂.၅၄ ကုဋေ
၁၀.၄၈ ကုဋေ
၇.၂၆ ကုဋေ
၁၂.၂၁ ကုဋေ
Net profit margin
-၅.၇၃%
၅.၁၅%
၃.၅၂%
၆.၀၃%
Earnings per share
၂.၅၂
၂.၅၀
၂.၅၆
၂.၆၆
Interest and investment income
၁.၄၉ သန်း
၁.၈၂ သန်း
၃.၁၆ သန်း
၅.၆၁ သန်း
Interest expense
-၄.၆၃ ကုဋေ
-၄.၈၀ ကုဋေ
-၄.၈၈ ကုဋေ
-၆.၆၂ ကုဋေ
Net interest expenses
-၄.၄၈ ကုဋေ
-၄.၆၂ ကုဋေ
-၄.၅၆ ကုဋေ
-၆.၀၆ ကုဋေ
Depreciation and amortization charges
-၂၉.၂၂ ကုဋေ
၉.၀၃ ကုဋေ
၉.၀၈ ကုဋေ
၈.၇၀ ကုဋေ
EBITDA
-၂၆.၄၂ ကုဋေ
၂၇.၇၃ ကုဋေ
၂၈.၅၀ ကုဋေ
၃၀.၄၂ ကုဋေ
Gain or loss from assets sale
-
-
၃.၂၉ ကုဋေ
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google အက်ပ်များ